Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin

Curran, C; Adib, E; Kazakova, V; Grivas, P; Diamantopoulos, LN; Alva, AS; Su, C; Jain, RK; Tandon, A; Necchi, A; Marandino, L; Plastini, TM; Merchan, JR; Sonpavde, G

Sonpavde, G (通讯作者)，Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.

CLINICAL GENITOURINARY CANCER, 2022; 20 (1): 11

Abstract

This retrospective study demonstrates poor outcomes of metastatic urothelial carcinoma patients following discontinuation of Enfortumab Vedotin (EV). ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索